Targeted Therapy in Head and Neck Cancer

被引：3
|
作者：
Ward, Brent B. [1 ]
机构：
[1] Univ Michigan, Ann Arbor, MI 48109 USA
来源：
ORAL AND MAXILLOFACIAL SURGERY CLINICS OF NORTH AMERICA | 2013年 / 25卷 / 01期
关键词：
Cancer; Nanotechnology; Chemotherapy; Radiation; Targeted therapy; SQUAMOUS-CELL CARCINOMA; TRANSORAL ROBOTIC SURGERY; LYMPH-NODE BIOPSY; SURGICAL MARGINS; PLUS CETUXIMAB; SIGNALING NETWORK; ANIMAL-MODEL; ORAL-CANCER; DISSECTION; CHEMOTHERAPY;
D O I：
10.1016/j.coms.2012.11.006
中图分类号：
R78 [口腔科学];
学科分类号：
1003 ;
摘要：
The desire to target therapies to specific cancers while leaving the host unharmed remains an ongoing quest for scientists, surgeons, radiation oncologists, and medical oncologists. In recent years, great scientific progress has been made in targeted therapies. Although many modalities remain in preclinical validation, some advances affect patient care today. This article summarizes the concepts of targeting and explores current examples of successful targeting and emerging targeting technologies in head and neck oncology.
引用
收藏
页码：83 / +
页数：12
相关论文
共 50 条
  • [41] Molecular-Targeted Therapies in Head and Neck Cancer
    Rao, Shyam D.
    Fury, Matthew G.
    Pfister, David G.
    SEMINARS IN RADIATION ONCOLOGY, 2012, 22 (03) : 207 - 213
  • [42] Targeted therapy for head and neck cancer: signaling pathways and clinical studies
    Li, Qingfang
    Tie, Yan
    Alu, Aqu
    Ma, Xuelei
    Shi, Huashan
    SIGNAL TRANSDUCTION AND TARGETED THERAPY, 2023, 8 (01)
  • [43] Advances in radiotherapy of head and neck cancers
    Tao, Yungan
    Daly-Schveitzer, Nicolas
    Lusinchi, Antoine
    Bourhis, Jean
    CURRENT OPINION IN ONCOLOGY, 2010, 22 (03) : 194 - 199
  • [44] Checkpoint inhibitors in head and neck cancer
    Sepulveda, Ilson
    Ascui, Rodrigo
    Capizzano, A. Andres
    MEMO-MAGAZINE OF EUROPEAN MEDICAL ONCOLOGY, 2019, 12 (03) : 249 - 252
  • [45] Role of Immunotherapy in Head and Neck Cancer
    Ling, Diane C.
    Bakkenist, Chris J.
    Ferris, Robert L.
    Clump, David A.
    SEMINARS IN RADIATION ONCOLOGY, 2018, 28 (01) : 12 - 16
  • [46] Targeted therapy for head and neck squamous cell carcinoma microenvironment
    Guo, Zhaomeng
    Li, Kang
    Liu, Peng
    Zhang, Xiangmin
    Lv, Jie
    Zeng, Xianhai
    Zhang, Peng
    FRONTIERS IN MEDICINE, 2023, 10
  • [47] Two cases of combination therapy with cetuximab, paclitaxel, and cisplatin for advanced head and neck cancer
    Hoch, Matthew A.
    Cousins, Kati
    Nartey, Ruth
    Riley, Keith
    Hartranft, Megan
    JOURNAL OF ONCOLOGY PHARMACY PRACTICE, 2018, 24 (07) : 553 - 554
  • [48] Combining Systemic Therapy With Radiation: Head and Neck Cancer Treatments in an Era of Targeted Agents and Immunotherapy
    Vasudevan, Harish N.
    Yom, Sue S.
    JOURNAL OF THE NATIONAL COMPREHENSIVE CANCER NETWORK, 2020, 18 (07): : 907 - 913
  • [49] Targeted Therapy in Head and Neck Cancer: An Update on Current Clinical Developments in Epidermal Growth Factor Receptor-Targeted Therapy and Immunotherapies
    Moreira, Jonathan
    Tobias, Alexander
    O'Brien, Michael P.
    Agulnik, Mark
    DRUGS, 2017, 77 (08) : 843 - 857
  • [50] Current State and Future Directions of EGFR-Directed Therapy in Head and Neck Cancer
    Tathineni, Praveena
    Joshi, Nikhil
    Jelinek, Michael J.
    CURRENT TREATMENT OPTIONS IN ONCOLOGY, 2023, 24 (06) : 680 - 692
12345